Non-alcoholic fatty liver disease (NAFLD) is a multifaceted metabolic disorder, whose
spectrum covers clinical, histological and pathophysiological developments ranging from …

The term non-alcoholic liver disease (NAFLD) was originally coined to describe hepatic fat
deposition as part of the metabolic syndrome. However, a variety of rare hereditary liver and …

Importance Prenatal exposures to endocrine-disrupting chemicals (EDCs) may increase the
risk for liver injury in children; however, human evidence is scarce, and previous studies …

Methods A search was conducted to include NASH RCTs with placebo treatment arms.
Primary outcomes were (1) the resolution of NASH without worsening of fibrosis,(2) two …

Genome-wide single nucleotide polymorphism (SNP) data are now quickly and
inexpensively acquired, raising the prospect of creating personalized dietary …

The identification of genetic variants associated with fatty liver disease (FLD) from genome
wide association studies (GWASs) started in 2008 when single nucleotide polymorphisms in …

Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide.
NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the …

Importance The onset age of nonalcoholic fatty liver disease (NAFLD) is decreasing, and
whether earlier ages of NAFLD onset are associated with increased cancer risk is currently …

The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated
fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the United States and worldwide. Though nonalcoholic fatty liver per se may not be …